Literature DB >> 19833013

Optimal treatment for hepatocellular carcinoma in the cirrhotic liver.

S A White1, D M Manas, S G Farid, K R Prasad.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19833013      PMCID： PMC2966157          DOI： 10.1308/003588409X464649

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


× No keyword cloud information.
  30 in total

1.  MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation.

Authors:  Marta Burrel; Josep M Llovet; Carmen Ayuso; Carmela Iglesias; Margarita Sala; Rosa Miquel; Teresa Caralt; Juan Ramon Ayuso; Manel Solé; Marcelo Sanchez; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

2.  Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria.

Authors:  Francis Y Yao; Linda Ferrell; Nathan M Bass; Peter Bacchetti; Nancy L Ascher; John P Roberts
Journal:  Liver Transpl       Date:  2002-09       Impact factor: 5.799

Review 3.  The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review.

Authors:  Wan Yee Lau; Eric C H Lai
Journal:  Ann Surg       Date:  2009-01       Impact factor: 12.969

4.  Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.

Authors:  F Y Yao; L Ferrell; N M Bass; J J Watson; P Bacchetti; A Venook; N L Ascher; J P Roberts
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

5.  Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto.

Authors:  I Levy; M Sherman
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

6.  Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.

Authors:  Francis Y Yao; Nathan M Bass; Bev Nikolai; Timothy J Davern; Robert Kerlan; Victor Wu; Nancy L Ascher; John P Roberts
Journal:  Liver Transpl       Date:  2002-10       Impact factor: 5.799

Review 7.  The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Authors:  Josep M Llovet; Josep Fuster; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

Review 8.  Small hepatocellular carcinoma: current status and prospects.

Authors:  Zhao-You Tang
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2002-08

9.  Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.

Authors:  Iwao Ikai; Shigeki Arii; Masamichi Kojiro; Takafumi Ichida; Masatoshi Makuuchi; Yutaka Matsuyama; Yasuni Nakanuma; Kiwamu Okita; Masao Omata; Kenichi Takayasu; Yoshio Yamaoka
Journal:  Cancer       Date:  2004-08-15       Impact factor: 6.860

10.  Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?

Authors:  René Adam; Daniel Azoulay; Denis Castaing; Rony Eshkenazy; Gérard Pascal; Kentaro Hashizume; Didier Samuel; Henri Bismuth
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.